S&P 500   2,749.87 (+3.24%)
DOW   23,509.22 (+3.66%)
QQQ   201.82 (+2.72%)
AAPL   269.69 (+2.75%)
MSFT   168.58 (+2.00%)
AMZN   1,997.59 (+0.00%)
CGC   15.05 (+7.81%)
BABA   196.45 (+0.00%)
GE   7.23 (+0.00%)
AMD   2.67 (-94.38%)
T   29.44 (+0.00%)
NFLX   379.96 (+0.00%)
GILD   77.73 (+0.00%)
PRI   91.33 (+7.54%)
S&P 500   2,749.87 (+3.24%)
DOW   23,509.22 (+3.66%)
QQQ   201.82 (+2.72%)
AAPL   269.69 (+2.75%)
MSFT   168.58 (+2.00%)
AMZN   1,997.59 (+0.00%)
CGC   15.05 (+7.81%)
BABA   196.45 (+0.00%)
GE   7.23 (+0.00%)
AMD   2.67 (-94.38%)
T   29.44 (+0.00%)
NFLX   379.96 (+0.00%)
GILD   77.73 (+0.00%)
PRI   91.33 (+7.54%)
S&P 500   2,749.87 (+3.24%)
DOW   23,509.22 (+3.66%)
QQQ   201.82 (+2.72%)
AAPL   269.69 (+2.75%)
MSFT   168.58 (+2.00%)
AMZN   1,997.59 (+0.00%)
CGC   15.05 (+7.81%)
BABA   196.45 (+0.00%)
GE   7.23 (+0.00%)
AMD   2.67 (-94.38%)
T   29.44 (+0.00%)
NFLX   379.96 (+0.00%)
GILD   77.73 (+0.00%)
PRI   91.33 (+7.54%)
S&P 500   2,749.87 (+3.24%)
DOW   23,509.22 (+3.66%)
QQQ   201.82 (+2.72%)
AAPL   269.69 (+2.75%)
MSFT   168.58 (+2.00%)
AMZN   1,997.59 (+0.00%)
CGC   15.05 (+7.81%)
BABA   196.45 (+0.00%)
GE   7.23 (+0.00%)
AMD   2.67 (-94.38%)
T   29.44 (+0.00%)
NFLX   379.96 (+0.00%)
GILD   77.73 (+0.00%)
PRI   91.33 (+7.54%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Capital Senior LivingDelta 9 CannabisAxovant Gene TherapiesMaxCyteApplied Genetic Technologies
SymbolNYSE:CSUCVE:NINENASDAQ:AXGTLON:MXCTNASDAQ:AGTC
Price Information
Current Price$0.61N/A$2.65GBX 125$3.34
52 Week RangeHoldN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationHoldN/ABuyN/ABuy
Consensus Price Target$3.15C$2.20$18.50N/A$16.50
% Upside from Price Target413.03% upside∞ upside598.11% upsideN/A394.01% upside
Trade Information
Market Cap$14.39 millionC$89.36 million$91.69 million£71.74 million$60.86 million
Beta1.78N/A1.26N/A2.91
Average Volume253,039117,300180,5791,951267,479
Sales & Book Value
Annual Revenue$447.10 millionC$12.87 millionN/A£18.11 million$41.69 million
Price / Sales0.040.00N/A3.961.46
Cashflow$0.89 per shareN/AN/AGBX 23.13 per shareN/A
Price / Cash0.6911.91N/A5.40N/A
Book Value$0.46 per shareC$0.53 per share$2.47 per shareGBX 28 per share$4.33 per share
Price / Book1.330.00N/A0.040.77
Profitability
Net Income$-36,030,000.00N/A$-129,070,000.00N/A$-2,010,000.00
EPS($1.48)C$0.05($8.02)GBX (25.40)($0.11)
Trailing P/E RatioN/A19.07N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-8.06%N/AN/AN/AN/A
Return on Equity (ROE)-240.37%N/A-241.62%N/A-26.07%
Return on Assets (ROA)-3.43%N/A-75.95%N/A-21.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio78.19%33.00%1.28%1.98%0.08%
Current Ratio0.49%4.44%1.09%2.64%4.33%
Quick Ratio0.49%2.04%1.09%2.11%4.33%
Ownership Information
Institutional Ownership Percentage63.35%N/A7.17%N/A45.78%
Insider Ownership Percentage18.60%N/A5.50%N/A3.10%
Miscellaneous
Employees6,6007945N/A78
Shares Outstanding31.46 million86.76 million36.82 million57.39 million18.22 million
Next Earnings Date5/14/2020 (Estimated)N/A6/9/2020 (Estimated)N/A5/5/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel